CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to AZN

Nexium 20mg

Phase 3
AstraZeneca PLC (AZN)

Phase 3

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Aug '26
AZNPhase 3
Positive

Nexium 20mg Phase 3 Est. Readout

Nexium 20mg
Aug 2026~
CT.gov
Competitive Landscape

0 competitors in Erosive Esophagitis

View Full Landscape
Drug Information

Target Indication

Erosive Esophagitis

Clinical Trial

NCT05267613

Last updated: 2/9/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.